Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Hea... by Leiter, Lawrence A., MD, Bays, Harold, MD, Conard, Scott, MD, Bird, Steven, MS, Rubino, Joseph, MBA, Hanson, Mary E., PhD, Tomassini, Joanne E., PhD, Tershakovec, Andrew M., MD

Get full text

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronar... by Conard, Scott E., MD, Bays, Harold E., MD, Leiter, Lawrence A., MD, Bird, Steven R., MS, Rubino, Joseph, MBA, Lowe, Robert S., PhD, Tomassini, Joanne E., PhD, Tershakovec, Andrew M., MD

Get full text

Comparative Efficacy of Ezetimibe Added to Atorvastatin vs. Uptitration of Atorvastatin in Attainment of Recommended Lipid Targets in Patients at High Risk for Coronary Heart Disea... by Conard, Scott E., MD, Leiter, Lawrence, Bays, Harold, Shah, Arvind, Lin, Jianxin, Hanson, Mary E, Tershakovec, Andrew M

Get full text

Does Baseline Body Mass Index, Fasting Blood Sugar, and High-Sensitivity C-Reactive Protein Influence the Efficacy of Adding Ezetimibe to Atorvastatin Versus Doubling the Atorvasta... by Bays, Harold Edward, MD, Conard, Scott, Leiter, Lawrence A, Bird, Steven, Shah, Arvind K, Lin, Jianxin, Lowe, Robert S, Tershakovec, Andrew M

Get full text

Do Age, Gender, and Race Affect the Efficacy of Ezetimibe Plus Atorvastatin vs. Doubling the Atorvastatin Dose in Moderately High and High CHD Risk Patients? by Bays, Harold Edward, MD, Conard, Scott, Leiter, Lawrence A, Bird, Steve, Lowe, Robert S, Tershakovec, Andrew M

Get full text

Effect of Ezetimibe Added to Atorvastatin on Lipoprotein Subclass Cholesterol Content in Patients with Higher Versus Lower Triglyceride Levels by Bays, Harold Edward, MD, Hanson, Mary E, Jensen, Erin, Shah, Arvind, Leiter, Lawrence, Conard, Scott, Tershakovec, Andrew M, Bird, Steve

Get full text